financial guidance Oct 28, 2021 Merck Q3 Revenues Grow 20 Percent With Keytruda as Top Seller Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Oct 30, 2019 Exact Sciences Preparing to Launch Improved Cologuard, Liver Cancer Test Premium Jul 29, 2019 Exact Sciences to Acquire Genomic Health for $2.8B; Q2 Revenues Rise 94 Percent Apr 30, 2019 Exact Sciences Q1 Revenues Up 79 Percent Breaking News California Governor Vetoes Biomarker Test Coverage Bill Massive Bio, Perthera Partner on Biomarker-Based Clinical Trial Matching Autolus Therapeutics, BMS Partner to Develop Cell Therapies Equipped With Safety Switches Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer FDA Approves Roche Antibody Test as CDx for Enhertu in HER2-Low Breast Cancer Patients Seneca Therapeutics Cleared by FDA to Start Phase I/II Oncolytic Virus Trial
